| UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
|||||||
|
Kinase Fusion Gene:JOSD1_FRK |
Kinase Fusion Protein Summary |
 Kinase Fusion gene summary |
| Kinase Fusion partner gene information | Kinase Fusion gene name: JOSD1_FRK | KinaseFusionDB ID: KFG2961 | FusionGDB2.0 ID: KFG2961 | Hgene | Tgene | Gene symbol | JOSD1 | FRK | Gene ID | 9929 | 2444 | |
| Gene name | Josephin domain containing 1 | fyn related Src family tyrosine kinase | ||||||||||
| Synonyms | dJ508I15.2 | GTK|PTK5|RAK | ||||||||||
| Cytomap | 22q13.1 | 6q22.1 | ||||||||||
| Type of gene | protein-coding | protein-coding | ||||||||||
| Description | josephin-1josephin domain-containing 1josephin domain-containing protein 1 | tyrosine-protein kinase FRKPTK5 protein tyrosine kinase 5fyn-related kinasenuclear tyrosine protein kinase RAKprotein-tyrosine kinase 5 | ||||||||||
| Modification date | 20240407 | 20240411 | ||||||||||
| UniProtAcc | Q15040 | P42685 | ||||||||||
| Ensembl transtripts involved in fusion gene | ENST ids | ENST00000216039, ENST00000462610, | ENST00000538210, ENST00000606080, | |||||||||
| Context (manual curation of fusion genes in KinaseFusionDB) | PubMed: JOSD1 [Title/Abstract] AND FRK [Title/Abstract] AND fusion [Title/Abstract] | |||||||||||
| Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | JOSD1(39081626)-FRK(116341485), # samples:1 | |||||||||||
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | FRK | GO:0000122 | negative regulation of transcription by RNA polymerase II | 12837246 |
| Kinase Fusion gene breakpoints across JOSD1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Kinase Fusion gene breakpoints across FRK (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Top |
Kinase Fusion Gene Sample Information |
| Kinase Fusion gene information. |
| Kinase Fusion gene information from four resources (ChiTars 5.0, ChimerDB 4.0, COSMIC, and CCLE) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Sample | Hgene | Hchr | Hbp | Tgene | Tchr | Tbp |
| ChiTaRS5.0 | BM014391 | JOSD1 | chr22 | 39081626 | FRK | chr6 | 116341485 |
Top |
Kinase Fusion ORF Analysis |
| Kinase Fusion information from ORFfinder translation from full-length transcript sequence from KinaseFusionDB. |
| Henst | Tenst | Hgene | Hchr | Hbp | Tgene | Tchr | Tbp | Seq length (transcript) | Seq length (amino acids) |
Top |
Kinase Fusion Amino Acid Sequences |
| For individual full-length fusion transcript sequence from KinaseFusionDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >Henst_Tenst_Hgene_Hchr_Hbp_Tgene_Tchr_Tbp_length(fusion AA)_AAseq |
Multiple Sequence Alignment of All Fusion Protein Isoforms |
Top |
Kinase Fusion Protein Functional Features |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:39081626/:116341485) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| JOSD1 | FRK |
| FUNCTION: Deubiquitinates monoubiquitinated probes (in vitro). When ubiquitinated, cleaves 'Lys-63'-linked and 'Lys-48'-linked poly-ubiquitin chains (in vitro), hence may act as a deubiquitinating enzyme. May increase macropinocytosis and suppress clathrin- and caveolae-mediated endocytosis. May enhance membrane dynamics and cell motility independently of its catalytic activity. {ECO:0000269|PubMed:21118805, ECO:0000269|PubMed:23625928}. | FUNCTION: Non-receptor tyrosine-protein kinase that negatively regulates cell proliferation. Positively regulates PTEN protein stability through phosphorylation of PTEN on 'Tyr-336', which in turn prevents its ubiquitination and degradation, possibly by reducing its binding to NEDD4. May function as a tumor suppressor. {ECO:0000269|PubMed:19345329}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - Retained domain in the 5'-partner of fusion protein (protein functional feature from UniProt). |
| Partner | Hgeneene | Hbp | Tgeneene | Tbp | ENST | BPexon | TotalExon | Protein feature loci | BPloci | TotalLen | Feature | Note |
| - Retained domain in the 3'-partner of fusion protein (protein functional feature from UniProt). |
| Partner | Hgeneene | Hbp | Tgeneene | Tbp | ENST | BPexon | TotalExon | Protein feature loci | BPloci | TotalLen | Feature | Note |
Top |
Kinase-Substrate Information of JOSD1_FRK |
| Phosphorylation target of the kinase (phosphosite, 03-17-2024) |
| Kinase | Kinase UniProt Acc | Kinase species | Substrate | Substrate UniProt Acc | Substrate phosphorylated residues | Substrate phosphorylated sites (+/-7AA) | Domain |
| FRK | P42685 | human | YAP1 | P46937 | Y407 | sGLsMsSySVPRtPD | |
| FRK | P42685 | human | BRCA1 | P38398 | Y1552 | HDLtEtSyLPRQDLE | |
| FRK | P42685 | human | YAP1 | P46937 | Y444 | QQNRFPDyLEAIPGT | |
| FRK | P42685 | human | YAP1 | P46937 | Y391 | PFLNsGtyHSRDEst | |
| FRK | P42685 | human | PTEN | P60484 | Y336 | NKDkANRyFSPNFKV | PTEN_C2 |
| Biological Network Integration of This Kinase and Substrates (GeneMANIA website) |
| Enriched GO biological processes of the phosphorylation target genes of the kinase |
| Kinase | GOID | GO term | P.adjust |
| FRK | ID | Description | 0.00e+00 |
| FRK | GO:2001236 | regulation of extrinsic apoptotic signaling pathway | 3.04e-04 |
| FRK | GO:0097191 | extrinsic apoptotic signaling pathway | 4.65e-04 |
| FRK | GO:0071214 | cellular response to abiotic stimulus | 7.24e-04 |
| FRK | GO:0104004 | cellular response to environmental stimulus | 7.24e-04 |
| FRK | GO:2001233 | regulation of apoptotic signaling pathway | 8.80e-04 |
| FRK | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway | 8.80e-04 |
| FRK | GO:1902116 | negative regulation of organelle assembly | 1.31e-03 |
| FRK | GO:1902041 | regulation of extrinsic apoptotic signaling pathway via death domain receptors | 1.36e-03 |
| FRK | GO:0030520 | intracellular estrogen receptor signaling pathway | 1.41e-03 |
| FRK | GO:0071479 | cellular response to ionizing radiation | 2.12e-03 |
| FRK | GO:0033143 | regulation of intracellular steroid hormone receptor signaling pathway | 2.12e-03 |
| FRK | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors | 2.70e-03 |
| FRK | GO:0046620 | regulation of organ growth | 3.07e-03 |
| FRK | GO:2001237 | negative regulation of extrinsic apoptotic signaling pathway | 3.07e-03 |
| FRK | GO:0031398 | positive regulation of protein ubiquitination | 3.54e-03 |
| FRK | GO:0030518 | intracellular steroid hormone receptor signaling pathway | 4.08e-03 |
| FRK | GO:1903322 | positive regulation of protein modification by small protein conjugation or removal | 4.40e-03 |
| FRK | GO:0010212 | response to ionizing radiation | 4.40e-03 |
| FRK | GO:0043401 | steroid hormone mediated signaling pathway | 4.40e-03 |
| FRK | GO:1901875 | positive regulation of post-translational protein modification | 5.55e-03 |
| FRK | GO:0035265 | organ growth | 6.53e-03 |
| FRK | GO:0071478 | cellular response to radiation | 6.53e-03 |
| FRK | GO:0031345 | negative regulation of cell projection organization | 6.74e-03 |
| FRK | GO:0009755 | hormone-mediated signaling pathway | 6.74e-03 |
| FRK | GO:1901991 | negative regulation of mitotic cell cycle phase transition | 6.74e-03 |
| FRK | GO:0031396 | regulation of protein ubiquitination | 6.75e-03 |
| FRK | GO:0071383 | cellular response to steroid hormone stimulus | 7.03e-03 |
| FRK | GO:1902115 | regulation of organelle assembly | 7.44e-03 |
| FRK | GO:1903320 | regulation of protein modification by small protein conjugation or removal | 8.17e-03 |
| FRK | GO:2001234 | negative regulation of apoptotic signaling pathway | 8.17e-03 |
| FRK | GO:0033002 | muscle cell proliferation | 8.17e-03 |
| FRK | GO:0045926 | negative regulation of growth | 8.17e-03 |
| FRK | GO:0045930 | negative regulation of mitotic cell cycle | 8.17e-03 |
| FRK | GO:1901988 | negative regulation of cell cycle phase transition | 9.89e-03 |
| FRK | GO:1901873 | regulation of post-translational protein modification | 1.01e-02 |
| FRK | GO:0060070 | canonical Wnt signaling pathway | 1.19e-02 |
| FRK | GO:0010948 | negative regulation of cell cycle process | 1.19e-02 |
| FRK | GO:0060485 | mesenchyme development | 1.19e-02 |
| FRK | GO:0048638 | regulation of developmental growth | 1.19e-02 |
| FRK | GO:0048545 | response to steroid hormone | 1.19e-02 |
| FRK | GO:0030522 | intracellular receptor signaling pathway | 1.31e-02 |
| FRK | GO:1901990 | regulation of mitotic cell cycle phase transition | 1.31e-02 |
| FRK | GO:0010639 | negative regulation of organelle organization | 1.34e-02 |
| FRK | GO:0050767 | regulation of neurogenesis | 1.45e-02 |
| FRK | GO:0045786 | negative regulation of cell cycle | 1.45e-02 |
| FRK | GO:0140694 | non-membrane-bounded organelle assembly | 1.45e-02 |
| FRK | GO:0001558 | regulation of cell growth | 1.45e-02 |
| FRK | GO:0042060 | wound healing | 1.45e-02 |
| FRK | GO:0007059 | chromosome segregation | 1.45e-02 |
Top |
Related Drugs to JOSD1_FRK |
| Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Drug | Source | PMID |
| Distribution of the number of studies mentioning JOSD1-FRK and kinase inhibitors the PubMed Abstract (04-01-2024) |
| Fusion gene - drug pair 1 | Fusion gene - drug pair 2 | PMID | Publication date | DOI | Study title |
Top |
Related Diseases to JOSD1_FRK |
| Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Disease | Source | PMID |
| Related diseases from the literature mentioned this fusion gene and drug. (PubMed, 04-01-2024) |
| MeSH ID | MeSH term |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Top |
Clinical Trials of the Found Drugs/Small Molecules |
| Statistics of the Clinical Trials of the Found Kinase Inibitors from clinicaltrials.gov (06-17-2024) |
| Clinical Trials from clinicaltrials.gov (06-17-2024) |
| Fusion Gene | Kinase Inhibitor | NCT ID | Study Status | Phases | Disease | # Enrolment | Date |
Copyright 2024-Present -The University of Texas Health Science Center at Houston
Web File Viewing | Emergency Information |Campus Carry|Site Policies |